186 related articles for article (PubMed ID: 12362295)
1. Treatment of recurrent hepatitis C.
Gane E
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S28-37. PubMed ID: 12362295
[TBL] [Abstract][Full Text] [Related]
2. Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation.
Ueda Y; Takada Y; Marusawa H; Egawa H; Uemoto S; Chiba T
Transplantation; 2010 Sep; 90(6):661-5. PubMed ID: 20110853
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hepatitis C virus infection and outcome after living-donor liver transplant.
Satapathy SK; Fiel MI; Vanatta JM; Del Rio Martin J; Schiano TD
Exp Clin Transplant; 2013 Dec; 11(6):522-9. PubMed ID: 23901801
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of recurrent hepatitis C infection after liver transplantation].
Filipec Kanizaj T; Colić Cvrlje V; Mrzljak A; Ostojić R
Acta Med Croatica; 2009 Dec; 63(5):451-7. PubMed ID: 20198907
[TBL] [Abstract][Full Text] [Related]
5. Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus.
Gurusamy KS; Tsochatzis E; Toon CD; Xirouchakis E; Burroughs AK; Davidson BR
Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006803. PubMed ID: 24307460
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatitis C in liver transplant recipients.
Gordon FD; Kwo P; Vargas HE
Liver Transpl; 2009 Feb; 15(2):126-35. PubMed ID: 19177439
[TBL] [Abstract][Full Text] [Related]
7. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
Fernández I; Meneu JC; Colina F; García I; Muñoz R; Castellano G; Fuertes A; Abradelo M; Lumbreras C; Moreno E; Solís-Herruzo JA
Liver Transpl; 2006 Dec; 12(12):1805-12. PubMed ID: 17133585
[TBL] [Abstract][Full Text] [Related]
9. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
10. Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.
Hanouneh IA; Miller C; Aucejo F; Lopez R; Quinn MK; Zein NN
Liver Transpl; 2008 Jan; 14(1):53-8. PubMed ID: 18161839
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
Zimmermann T; Böcher WO; Biesterfeld S; Zimmermann A; Kanzler S; Greif-Higer G; Barreiros AP; Sprinzl MF; Wörns MA; Lohse AW; Mönch C; Otto G; Galle PR; Schuchmann M
Transpl Int; 2007 Jul; 20(7):583-90. PubMed ID: 17433090
[TBL] [Abstract][Full Text] [Related]
12. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
Neff GW; O'Brien CB; Cirocco R; Montalbano M; de Medina M; Ruiz P; Khaled AS; Bejarano PA; Safdar K; Hill MA; Tzakis AG; Schiff ER
Liver Transpl; 2004 May; 10(5):595-8. PubMed ID: 15108250
[TBL] [Abstract][Full Text] [Related]
13. Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series.
Mukherjee S; Lyden E
Hepatogastroenterology; 2006; 53(70):561-5. PubMed ID: 16995462
[TBL] [Abstract][Full Text] [Related]
14. Consensus Interferon for Recurrent Hepatitis C Infection in Nonresponders to Peginterferon and Ribavirin After Liver Transplant.
Nordstrom EM; Biggins SW; Gralla J; Rosen HR; Everson GT; Burton JR
Exp Clin Transplant; 2015 Dec; 13(6):543-9. PubMed ID: 26643674
[TBL] [Abstract][Full Text] [Related]
15. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Reed A; Hemming A; Howard R; Van Der Werf W; Lauwers G; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2002 Nov; 8(11):1000-6. PubMed ID: 12424712
[TBL] [Abstract][Full Text] [Related]
16. Sustained clearance of serum hepatitis C virus-RNA independently predicts long-term survival in liver transplant patients with recurrent hepatitis C.
Kornberg A; Küpper B; Tannapfel A; Thrum K; Bärthel E; Habrecht O; Settmacher U
Transplantation; 2008 Aug; 86(3):469-73. PubMed ID: 18698252
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
Castells L; Vargas V; Allende H; Bilbao I; Luis Lázaro J; Margarit C; Esteban R; Guardia J
J Hepatol; 2005 Jul; 43(1):53-9. PubMed ID: 15876467
[TBL] [Abstract][Full Text] [Related]
18. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
Bizollon T; Ducerf C; Trépo C
J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
[TBL] [Abstract][Full Text] [Related]
19. Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation.
Mukherjee S
Transplant Proc; 2005 Dec; 37(10):4403-5. PubMed ID: 16387131
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin.
Neumann U; Puhl G; Bahra M; Berg T; Langrehr JM; Neuhaus R; Neuhaus P
Transplantation; 2006 Jul; 82(1):43-7. PubMed ID: 16861940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
